PDE4 inhibitors block intracellular TLR signaling and promote apoptosis of chronic lymphocytic leukemia (CLL) cells through increasing cAMP concentration [112, 113]. The gene discussed is PDE4A; the disease is B-cell chronic lymphocytic leukemia.